BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20959150)

  • 21. Osteoclastogenesis in iliac bone marrow of patients with rheumatoid arthritis.
    Toritsuka Y; Nakamura N; Lee SB; Hashimoto J; Yasui N; Shino K; Ochi T
    J Rheumatol; 1997 Sep; 24(9):1690-6. PubMed ID: 9292789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated osteoclastogenesis is related to natural killer T cell dysfunction in rheumatoid arthritis.
    Jin HM; Kee SJ; Cho YN; Kang JH; Kim MJ; Jung HJ; Park KJ; Kim TJ; Lee SI; Choi H; Koh JT; Kim N; Park YW
    Arthritis Rheumatol; 2015 Oct; 67(10):2639-50. PubMed ID: 26097058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synovial macrophage-osteoclast differentiation in inflammatory arthritis.
    Danks L; Sabokbar A; Gundle R; Athanasou NA
    Ann Rheum Dis; 2002 Oct; 61(10):916-21. PubMed ID: 12228163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
    Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B
    Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
    Nakano K; Okada Y; Saito K; Tanaka Y
    Arthritis Rheum; 2004 Aug; 50(8):2450-8. PubMed ID: 15334457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients.
    Takano H; Tomita T; Toyosaki-Maeda T; Maeda-Tanimura M; Tsuboi H; Takeuchi E; Kaneko M; Shi K; Takahi K; Myoui A; Yoshikawa H; Takahashi T; Suzuki R; Ochi T
    Rheumatology (Oxford); 2004 Apr; 43(4):435-41. PubMed ID: 14762224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients.
    Lisignoli G; Piacentini A; Cristino S; Grassi F; Cavallo C; Cattini L; Tonnarelli B; Manferdini C; Facchini A
    J Cell Physiol; 2007 Mar; 210(3):798-806. PubMed ID: 17133360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
    Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M
    Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.
    Roato I; Grano M; Brunetti G; Colucci S; Mussa A; Bertetto O; Ferracini R
    FASEB J; 2005 Feb; 19(2):228-30. PubMed ID: 15550550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent.
    Itonaga I; Fujikawa Y; Sabokbar A; Murray DW; Athanasou NA
    J Pathol; 2000 Sep; 192(1):97-104. PubMed ID: 10951406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis.
    Knowles HJ; Athanasou NA
    J Pathol; 2009 Jun; 218(2):256-64. PubMed ID: 19291710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
    Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S
    J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
    Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory T cells protect from local and systemic bone destruction in arthritis.
    Zaiss MM; Frey B; Hess A; Zwerina J; Luther J; Nimmerjahn F; Engelke K; Kollias G; Hünig T; Schett G; David JP
    J Immunol; 2010 Jun; 184(12):7238-46. PubMed ID: 20483756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT.
    Mabilleau G; Pascaretti-Grizon F; Baslé MF; Chappard D
    Cytokine; 2012 Feb; 57(2):294-9. PubMed ID: 22172512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells.
    Ogawa Y; Ohtsuki M; Uzuki M; Sawai T; Onozawa Y; Nakayama J; Yonemura A; Kimura T; Matsuno H
    Arthritis Rheum; 2003 Dec; 48(12):3350-8. PubMed ID: 14673986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cell-substrate interaction in regulating osteoclast activation: potential implications in targeting bone loss in rheumatoid arthritis.
    McHugh KP; Shen Z; Crotti TN; Flannery MR; O'Sullivan RP; Purdue PE; Goldring SR
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i83-85. PubMed ID: 19995752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
    Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
    Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.